10-08-2025
Frontken Corporation Berhad Second Quarter 2025 Earnings: EPS: RM0.021 (vs RM0.021 in 2Q 2024)
Explore Frontken Corporation Berhad's Fair Values from the Community and select yours
Frontken Corporation Berhad (KLSE:FRONTKN) Second Quarter 2025 Results
Key Financial Results
Revenue: RM156.4m (up 16% from 2Q 2024).
Net income: RM33.5m (flat on 2Q 2024).
Profit margin: 21% (down from 25% in 2Q 2024). The decrease in margin was driven by higher expenses.
EPS: RM0.021 (in line with 2Q 2024).
AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.
All figures shown in the chart above are for the trailing 12 month (TTM) period
Frontken Corporation Berhad Earnings Insights
Looking ahead, revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 12% growth forecast for the Commercial Services industry in Asia.
Performance of the market in Malaysia.
The company's shares are up 6.6% from a week ago.
Balance Sheet Analysis
While it's very important to consider the profit and loss statement, you can also learn a lot about a company by looking at its balance sheet. We've done some analysis and you can see our take on Frontken Corporation Berhad's balance sheet.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
